hC Bioscience
Cambridge
About hC Bioscience
HC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA. Their First in Class approach for protein editing advances beyond genome editing to direct modification of the proteome.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $40.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2022)
- Website: hcbioscience.com
- Phone: 617-515-6755
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/hc-bioscience-124151 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.